Singapore markets close in 3 hours 38 minutes
Straits Times Index
3,364.86 -13.43 (-0.40%) Nikkei
27,370.59 -62.81 (-0.23%) Hang Seng
21,770.15 -299.58 (-1.36%) FTSE 100
7,784.87 +19.72 (+0.25%) BTC-USD
22,874.63 -826.57 (-3.49%) CMC Crypto 200
519.02 -18.85 (-3.50%)
LLY Sep 2023 330.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 12:46PM EST. Market open.
| Previous close | 44.40 |
| Open | 45.78 |
| Bid | 38.95 |
| Ask | 41.70 |
| Strike | 330.00 |
| Expiry date | 2023-09-15 |
| Day's range | 44.40 - 45.78 |
| Contract range | N/A |
| Volume | |
| Open interest | 109 |
- Zacks
Eli Lilly (LLY) Lymphoma Candidate Pirtobrutinib Gets FDA Nod
The FDA approves Eli Lilly's Jaypirca (pirtobrutinib) under an accelerated approval pathway as a treatment for mantle cell lymphoma (MCL).
- Zacks
FDA Pulls EUA Granted to AstraZeneca's (AZN) Evusheld
AstraZeneca's (AZN) Evusheld is no longer authorized for use in the United States after laboratory data showed that it does not neutralize Omicron subvariants.
- Zacks
Biogen (BIIB) & Eisai's Lecanemab Secures EMA's MAA Acceptance
Biogen (BIIB) and Eisai jointly announce that EMA accepts lecanemab's marketing authorization application (MAA) for the treatment of patients with early-stage Alzheimer's disease, for review.
© 2023 Yahoo. All rights reserved.
